Most protocols recommend administration in a fasted state, typically first thing in the morning before breakfast
Because of this low oral bioavailability, clinical formulations of ALCAR must be dosed high enough to ensure that an adequate amount of the active compound survives the digestive process and reaches the blood-brain barrier
However, it has been demonstrated that necrosis can be driven and regulated by certain molecular mechanisms, similar to apoptosis, in a process called necroptosis 103
[26] Lower doses may be used in women at risk for OHSS
Gentile, E., Quitadamo, S
The rationale is rooted in preventing receptor desensitization, maintaining optimal cellular responsiveness, and allowing for the re-establishment of baseline physiological parameters